@kimmonismus: drug discovery as Anthropic's next big revenue stream, and Dario on leaving OpenAI

@kimmonismus thinks drug discovery will become one of the AI labs' most significant revenue streams (his opinion), and shared a clip of Dario Amodei explaining that he left OpenAI over trust in how safety disagreements were handled.

Why it mattersContext rather than action: expect labs to keep building sector-specific packages like this, which is exactly where niche consultants can add value.

Curated by Sara Simeone as part of our human editorial coverage. The original sources are linked below; curation is distinct from a Hype or Fact? assessment.

How we knowCompany figures are labelled as their own claims; anything we couldn't verify is labelled as a report or a claim.